Mike Polark
Stock Analyst at Wolfe Research
(3.17)
# 1,027
Out of 4,650 analysts
75
Total ratings
46.51%
Success rate
3.02%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Downgrades: Underperform | $180 | $244.40 | -26.35% | 5 | Sep 18, 2024 | |
| ZBH Zimmer Biomet Holdings | Initiates: Peer Perform | n/a | $103.88 | - | 1 | Sep 10, 2024 | |
| SYK Stryker | Initiates: Outperform | $405 | $359.01 | +12.81% | 1 | Sep 10, 2024 | |
| LIVN LivaNova | Maintains: Neutral | $55 | $52.97 | +3.83% | 8 | Aug 28, 2024 | |
| NVRO Nevro | Upgrades: Peer Perform | n/a | $5.25 | - | 9 | Aug 8, 2024 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $220 → $200 | $199.10 | +0.45% | 4 | Aug 7, 2024 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $120 → $110 | $77.00 | +42.86% | 6 | Aug 2, 2024 | |
| EW Edwards Lifesciences | Upgrades: Peer Perform | n/a | $69.37 | - | 3 | Jul 29, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $487 → $503 | $516.31 | -2.58% | 7 | Jul 19, 2024 | |
| PODD Insulet | Upgrades: Outperform | $200 | $232.37 | -13.93% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $70.24 | - | 3 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $113.40 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $236.44 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $72.24 | +67.50% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $32.93 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $15.92 | +57.04% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $141.05 | +16.98% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $84.56 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | n/a | $90.32 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $6.49 | +100.31% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $9.46 | +121.99% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $223.87 | +11.67% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $2.41 | +1,684.23% | 1 | Sep 2, 2020 |
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $244.40
Upside: -26.35%
Zimmer Biomet Holdings
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $103.88
Upside: -
Stryker
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $359.01
Upside: +12.81%
LivaNova
Aug 28, 2024
Maintains: Neutral
Price Target: $55
Current: $52.97
Upside: +3.83%
Nevro
Aug 8, 2024
Upgrades: Peer Perform
Price Target: n/a
Current: $5.25
Upside: -
Inspire Medical Systems
Aug 7, 2024
Maintains: Outperform
Price Target: $220 → $200
Current: $199.10
Upside: +0.45%
iRhythm Technologies
Aug 2, 2024
Maintains: Outperform
Price Target: $120 → $110
Current: $77.00
Upside: +42.86%
Edwards Lifesciences
Jul 29, 2024
Upgrades: Peer Perform
Price Target: n/a
Current: $69.37
Upside: -
Intuitive Surgical
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $516.31
Upside: -2.58%
Insulet
May 7, 2024
Upgrades: Outperform
Price Target: $200
Current: $232.37
Upside: -13.93%
Jan 9, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $70.24
Upside: -
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $113.40
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $236.44
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $72.24
Upside: +67.50%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $32.93
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $15.92
Upside: +57.04%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $141.05
Upside: +16.98%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $84.56
Upside: -
Jul 6, 2022
Initiates: Underperform
Price Target: n/a
Current: $90.32
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $6.49
Upside: +100.31%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $9.46
Upside: +121.99%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $223.87
Upside: +11.67%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $2.41
Upside: +1,684.23%